Erasca director granted 29,888 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. director James Arthur Bristol received a grant of stock options as part of his compensation. The award covers 29,888 options to buy common stock at an exercise price of $16.01 per share. These options were granted at no cost on the grant date.
The options vest 100% on June 26, 2027, provided he continues serving the company through that date, and they expire on June 26, 2036. After this grant, he holds 29,888 stock options directly, with no open-market share purchases or sales reported in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 29,888 | $0.00 | $0.00 |
Footnotes (1)
- F1. 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.
Key Figures
Key Terms
Stock option financial
exercise price financial
Grant, award, or other acquisition financial
vest financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Erasca (ERAS) director James Arthur Bristol report on this Form 4?
What is the exercise price of the Erasca (ERAS) options granted to James Arthur Bristol?
When do James Arthur Bristol’s Erasca (ERAS) stock options vest and expire?
How many Erasca (ERAS) stock options does James Arthur Bristol hold after this transaction?
Is this Erasca (ERAS) Form 4 filing a stock purchase or sale by James Arthur Bristol?
AI-generated analysis. How Rhea-AI works. Not financial advice.